NAPS Global India IPO has received a muted response from investors so far, with the subscription reaching nearly 42 per cent ...

The NAPS Global India IPO launched on March 5, priced at ₹90 per share, with a minimum bid of 1,600 shares. The company, a ...

To advance the University of North Georgia’s international agenda, Cadet Leadership Programs works with the whole of the university to mobilize research capability, increase and strengthen scholarship ...

At the upper end, NAPS Global India seeks to raise Rs 11.88 crore from the public offering, which comprises an entirely fresh ...

Pharma GMP and Quality Management 2025 to be held in Mumbai on April 24: Our Bureau, Mumbai Monday, March 3, 2025, 09:00 Hrs [IST] The pharmaceutical industry is underg ...

NAPS Global India's SME IPO opened for bidding, aiming to raise Rs 12 crore with a price band of Rs 90 per share.

WuXi Biologics (stock code: 2269) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and ...

About Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) The Pharmaceutical Inspection Co-operation Scheme (PIC/S) is a global initiative aimed at ...

WuXi Biologics passes GMP inspection by Japan PMDA for its drug substance facilities in Wuxi city: Wuxi, China Friday, February 28, 2025, 15:00 Hrs [IST] WuXi Biologics (WuXi Bio) ...

The Stability Program is being conducted in collaboration with HYTN’s GMP-licensed laboratory partner. Upon successful completion, HYTN expects to provide an initial six-month stability statement for ...